Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Rudwaleit

Showing results (51-60 of 150) with videos related to

Pageof 15
Sort By:
The Journal of Rheumatology|January 19, 2008
New onset of Crohn's disease during treatment of active ankylosing spondylitis with etanerceptIn-Ho Song, Heiner Appel, Hildrun Haibel, et al.
Therapeutic Advances in Musculoskeletal Disease|September 4, 2023
Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthritisMartin Rudwaleit, Pedro M Machado, Vanessa Taieb, et al.
Therapeutic Advances in Musculoskeletal Disease|June 9, 2025
Uveitis in patients with axial spondyloarthritis or psoriatic arthritis: a post hoc analysis from placebo-controlled phase III studies with secukinumabJan Brandt-Jürgens, Martin Rudwaleit, Frank Behrens, et al.
RMD Open|November 30, 2023
Work productivity in patients with axial spondyloarthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review and meta-analysisMartin Rudwaleit, Michael F Mørup, Brittany Humphries, et al.
Annals of the Rheumatic Diseases|August 20, 2013
Elevated serum level of the vascular endothelial growth factor predicts radiographic spinal progression in patients with axial spondyloarthritisDenis Poddubnyy, Kristina Conrad, Hildrun Haibel, et al.
The Journal of Rheumatology|March 3, 2004
Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanerceptJan Brandt, Andre Khariouzov, Joachim Listing, et al.
Annals of the Rheumatic Diseases|May 31, 2011
Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritisDenis Poddubnyy, Martin Rudwaleit, Hildrun Haibel, et al.
Arthritis and Rheumatism|February 28, 2009
The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception CohortMartin Rudwaleit, Hildrun Haibel, Xenofon Baraliakos, et al.
Arthritis and Rheumatism|June 26, 2008
Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-twoHildrun Haibel, Martin Rudwaleit, Joachim Listing, et al.
Rheumatology (Oxford, England)|July 26, 2020
Assessment of radiographic sacroiliitis in anteroposterior lumbar vs conventional pelvic radiographs in axial spondyloarthritisValeria Rios Rodriguez, Maria Llop, Mikhail Protopopov, et al.
Pageof 15

Showing results (51-60 of 150) with videos related to

Sort By:
Pageof 15
The Journal of Rheumatology|January 19, 2008
New onset of Crohn's disease during treatment of active ankylosing spondylitis with etanerceptIn-Ho Song, Heiner Appel, Hildrun Haibel, et al.
Therapeutic Advances in Musculoskeletal Disease|September 4, 2023
Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthritisMartin Rudwaleit, Pedro M Machado, Vanessa Taieb, et al.
Therapeutic Advances in Musculoskeletal Disease|June 9, 2025
Uveitis in patients with axial spondyloarthritis or psoriatic arthritis: a post hoc analysis from placebo-controlled phase III studies with secukinumabJan Brandt-Jürgens, Martin Rudwaleit, Frank Behrens, et al.
RMD Open|November 30, 2023
Work productivity in patients with axial spondyloarthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review and meta-analysisMartin Rudwaleit, Michael F Mørup, Brittany Humphries, et al.
Annals of the Rheumatic Diseases|August 20, 2013
Elevated serum level of the vascular endothelial growth factor predicts radiographic spinal progression in patients with axial spondyloarthritisDenis Poddubnyy, Kristina Conrad, Hildrun Haibel, et al.
The Journal of Rheumatology|March 3, 2004
Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanerceptJan Brandt, Andre Khariouzov, Joachim Listing, et al.
Annals of the Rheumatic Diseases|May 31, 2011
Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritisDenis Poddubnyy, Martin Rudwaleit, Hildrun Haibel, et al.
Arthritis and Rheumatism|February 28, 2009
The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception CohortMartin Rudwaleit, Hildrun Haibel, Xenofon Baraliakos, et al.
Arthritis and Rheumatism|June 26, 2008
Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-twoHildrun Haibel, Martin Rudwaleit, Joachim Listing, et al.
Rheumatology (Oxford, England)|July 26, 2020
Assessment of radiographic sacroiliitis in anteroposterior lumbar vs conventional pelvic radiographs in axial spondyloarthritisValeria Rios Rodriguez, Maria Llop, Mikhail Protopopov, et al.
Pageof 15